We bring the “Miracle in medicine” for a better Future/Mirai to the lives of people.
Latest NewsMore News
- June 29, 2020InformationNEW
- Jun 29: Our company has been selected for NEDO’s (New Energy and Industrial Technology Development Organization) FY2020 “Research and Development Venture Support Program / Commercialization Support for Research and Development Ventures at Seed Stage”. The title of the grant is “Verification of the Pharmaceutical Properties of Met Agonists for the Treatment of NASH” and we will promote our own development project.
- January 27, 2020Information
- Feb 8 [Japanese Only] President Kato appeared at BS Fuji “konokuninoyukusue2 (every Saturday from 18:00 to 18:30)”, introduced our business (Part 2).
- January 27, 2020Information
- Feb 1 [Japanese Only] President Kato appeared at BS Fuji “konokuninoyukusue2 (every Saturday from 18:00 to 18:30)”, introduced our business (Part 1).
- January 17, 2020Information
- Jan. 15: Notice Concerning Third Party Allocation ／ In order to further accelerate the business, MiraBiologics Inc. announces the completion of 550 million Japanese Yen (US$ 5 Million, as of Jan. 10, 2020) private financing, led by Shinsei Capital Partners Ltd. as a lead investor, and , SMBC Venture Capital Co., Ltd, SBI Investment Co., Ltd.
- January 10, 2020Information
- Nov. 28: At the “Forbes JAPAN CEO Conference” hosted by Forbes JAPAN, we received the “Mizuho Award”, a special award at the “Japanese Entrepreneurs Ranking” award ceremony (PDF attached, Japanese only).
- There are no articles yet.
